Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin

被引：0
|
作者：
Lin, Iris
Horblyuk, Ruslan
Mardekian, Jack
Park, Sang Hee
Kamble, Shital
Hamilton, Melissa
Abdulsattar, Younos
Petkun, William
Menzin, Joseph
Lip, Gregory Y.
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Atrial fibrillation; Anticoagulants; Warfarin; Hemorrhage; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13828
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Clinical Drug Investigation, 2014, 34 : 9 - 17
  • [32] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 9 - 17
  • [33] Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure
    Martinez, Brandon K.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Sood, Nitesh A.
    Coleman, Craig I.
    ESC HEART FAILURE, 2019, 6 (01): : 10 - 15
  • [34] Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin
    Alpesh, Amin N.
    Keshishian, Allison
    Xie, Lin
    Baser, Onur
    Price, Kwanza
    Vo, Lien
    Singh, Prianka
    Bruno, Amanda
    Mardekian, Jack
    Tan, Wilson
    Singhal, Shalabh
    Patel, Chad
    Odell, Kevin
    Trocio, Jeffrey
    BLOOD, 2015, 126 (23)
  • [35] Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Alonso, Alvaro
    JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 868 - 876
  • [36] Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK
    Ridha, E.
    Johnson, M.
    Lacoin, L.
    Collings, S. L.
    Parsons, V.
    Kloss, S.
    Stynes, G.
    Maguire, A.
    Lefevre, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 493 - 493
  • [37] REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN
    Tepper, Ping
    Mardekian, Jack
    Masseria, Cristina
    Horblyuk, Ruslan
    Kamble, Shital
    Hamilton, Melissa
    Abdulsattar, Younos
    Petkun, William
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 662 - 662
  • [38] FACTORS ASSOCIATED WITH BLEEDING EVENTS IN PATIENTS ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION: A REAL WORLD EXPERIENCE
    Akhtar, Tauseef
    Mattumpuram, Jishanth
    Fugar, Setri
    Ranka, Sagar
    Fratti, Juan Del Cid
    Mann, Hashim
    Uprety, Alok
    Putta, Aakash
    Golzar, Yasmeen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 471 - 471
  • [39] Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation
    Marx, S.
    Diener, H. -C.
    Harenberg, J.
    Lip, G.
    Marder, V.
    Wehling, M.
    Weiss, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 815 - 815
  • [40] Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients
    Lip, Gregory Y.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Liu, Larry Z.
    Lawrence, John
    Dorian, Paul
    CIRCULATION, 2014, 130
12345